MitoQ

Human Longevity, Inc: $30m injection. Challenges?

Latest articles

Fetch! Solving dog longevity can benefit us all

Loyal founder Celine Halioua talks about the inspiration behind her journey into aging science and why dog longevity has relevance in humans. Earlier this week,...

Small is mighty when it comes to mitochondria supplements

Optimise, energise, revitalise – MitoQ is on a mission to supplement your mitochondrial health. Coenzyme Q10 – or CoQ10 – is made naturally in the...

InVivo launches new platform for antiaging R&D

InVivo Biosystems' new analysis platform aims to accelerate product development timelines and increase consumer confidence in claims of improved outcomes via scientific validation. InVivo Biosystems,...

Lack of tryptophan spells microbiome trouble as we age

Researchers find that with age, insufficient amounts of the amino acid tryptophan can alter gut microbiota and increase inflammation. The essential amino acid tryptophan plays...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...
fundraising

Editor's picks

Fetch! Solving dog longevity can benefit us all

Loyal founder Celine Halioua talks about the inspiration behind her journey into aging science and why dog longevity has relevance in humans. Earlier this week,...

Small is mighty when it comes to mitochondria supplements

Optimise, energise, revitalise – MitoQ is on a mission to supplement your mitochondrial health. Coenzyme Q10 – or CoQ10 – is made naturally in the...

InVivo launches new platform for antiaging R&D

InVivo Biosystems' new analysis platform aims to accelerate product development timelines and increase consumer confidence in claims of improved outcomes via scientific validation. InVivo Biosystems,...
MitoQ

Click the globe for translations.

Trouble in paradise? Or extra funding for new goals in precision health analytics?

The abrupt press announcement on the Human Longevity, Inc. website was one of the shortest we’ve seen:

Human Longevity, Inc (“HLI”), an innovator in providing data-driven precision health intelligence platform for physicians and patients, today announced a $30 million financing from veteran biotech investment firms and investors. Existing investor Emerging Technology Partners LLC participated in the financing with other new dedicated healthcare investors.

HLI’s statement said it will use the proceeds from this new round to enhance its Health Nucleus intelligence platform, a research and discovery centre in California which is using integrated metrics derived from specialised imaging, whole genome sequencing and other lab tests with machine learning and AI to create a comprehensive standard for measuring your health and performance and increase healthspan.

It has been over a year since the company issued its last press release. Hmm.

A quick look at Glassdoor indicates some staffing issues – we realise this is a blunt research tool, as most satisfaction surveys are more actively used by the disgruntled – however the $30m could well be bridging ahead of a much larger round: according to Crunchbase the previous $220m Series B round was led by Illumina Ventures while this most recent injection has been led by Emerging Technology Partners.

The San Diego based venture was founded by Craig Venter and Peter Diamandis in 2013. The company is an early mover in advanced diagnostic tools and has a data-driven precision health intelligence platform for detecting diseases before they evolve into bigger problems for both doctors and patients.

Health intelligence has grown substantially over recent years, with technology enabling us to gain a deeper understanding of how we can take a proactive, rather than reactive, approach to aging and health. Human Longevity, Inc states this is the beginning of an era of health intelligence based on their new platform targeting healthspan.

Back in 2017 Venter stated, “We have sequencing that’s better than anybody else in the world. We have the most accurate data” [1]. However, with the average prices for assessments ranging from $5,500 to $25,000, their novel approach to preventive medicine may be out of reach for most. [2].

A handful of competitors appear to be racing ahead, including 23AndMe, Cesca Therapeutics and Pieriandx [3]

[1] https://bit.ly/2Q1VJO3
[2] https://bit.ly/2CqEEFJ
[3] https://www.owler.com/company/humanlongevity

Image: Glen Jackson on Unsplash

 

1 COMMENT

Comments are closed.

Salvinija Roznyte
Staff Writer Salvinija Roznyte is a writer and journalist based in London. She graduated in 2018 with a Bachelor's degree majoring in Writing and Journalism with a minor in Film Studies. She is interested in the way modern medical technology changes and shapes our world.
MitoQ

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...
fundraising

Related articles

Insilico Medicine gets $255m boost for AI-powered R&D

Insilico closes $255 million to progress into human clinical trials and develop novel targets and also announces Teva Pharm collaboration. Insilico Medicine, a company driving...

Longevity focused crypto platform to launch token auction

Lead researcher behind VitaDAO’s first project reveals more about his work and why crypto provides an exciting new funding option for longevity scientists. Later this...

Calling all longevity start-ups and scale-ups

Some news from us! Longevity.Technology's brand-new investment portal brings innovators and investors together. As a part of our mission to support the companies that will...

Oisín seed raise advances therapies for diseases of aging

Oisín Biotechnologies funding tops $9.5 million, with additional funding set to support preclinical development of its platform and investigational therapy for kidney and other age-related diseases. Seattle-based...

Dorian and HitGen to collaborate on senotherapy

Send in the senoblockers – Dorian and HitGen announce a research collaboration focused on DNA-encoded library-based drug discovery for age-related diseases. HitGen, Inc today announced...
Supps report ad middle